Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-thumbnail_1

Up to 60,000 in the UK may have suffered from “long COVID” new data suggests

September 8, 2020
Manufacturing and Production Vaccine, pandemic, vaccines

60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …

News
genentech_web

Genetech scores sixth FDA approval in lung cancer with Gavreto

September 7, 2020
Sales and Marketing Cancer, FDA, Genentech, lung cancer

Genentech’s once-daily oral therapy Gavreto (pralsetinib) has secured FDA backing in the treatment of metastatic rearranged during transfection (RET) fusion-positive …

News
800px-sanofi_frankfurt_iph

President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros

September 7, 2020
Sales and Marketing COVID-19, GSK, Sanofi

The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros.  …

News
janssen_latest_logo_on_sign

Janssen’s Imbruvica secures label expansion in Europe in chronic lymphocytic leukaemia

September 7, 2020
Sales and Marketing Europe, Janssen, imbruvica, pharma

The European Commission (EC) has moved to expand the existing approval of Janssen’s Imbruvica (ibrutinib) in chronic lymphocytic leukaemia (CLL) …

News
fda_21

FDA rejects oleandrin as a dietary supplement, after being touted by major Trump ally as a coronavirus treatment

September 7, 2020
Sales and Marketing FDA, coronavirus, fda treatment

The FDA has rejected a submission from Phoenix Biotechnology to market oleandrin as a dietary supplement.  Phoenix Biotechnology submitted oleandrin …

News
vaccination-1215279_960_720

New poll indicates most Americans will not get a COVID-19 vaccine when it’s first available

September 7, 2020
Sales and Marketing COVID, COVID-19, COVID-19 vaccine, coronavirus

Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …

News
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020
Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …

News
images_1

Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November

September 4, 2020
Medical Communications

Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the …

News
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020
Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.

News
shutterstock_159488225

Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety

September 4, 2020
Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat

Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 4, 2020
Medical Communications

The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …

News

NICE knocks back Janssen’s Spravato nasal spray for the second time in treatment-resistant depression

September 3, 2020
Sales and Marketing Janssen, Spravato, depression, pharma

NICE has opted to reject Janssen’s nasal spray Spravato (esketamine) for routine use on the NHS for treatment-resistant major depressive …

News
img_4190-e1376666350337-web

MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme

September 3, 2020
Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma

It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …

News
gustave_perna_29510410783

Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report

September 3, 2020
Research and Development

Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …

News
800px-ted_cruz_39609752645

Ted Cruz and 19 other GOP Senators ask FDA to remove Danco’s abortion drug Mifeprex from the market

September 3, 2020
Manufacturing and Production Mifeprex, abortion

Texas Senator Ted Cruz and 19 other senators have sent a letter to the FDA urging them to take the …

News
tiktok-5323005_960_720

J&J issues warning after teen dies from Benadryl TikTok challenge

September 3, 2020
Medical Communications

One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …

News
shutterstock_138095450

Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+

September 2, 2020
Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma

Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …

News
800px-president_trump_delivers_remarks_at_the_white_house_coronavirus_task_force_briefing_49716740721

US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO

September 2, 2020
Research and Development Trump, Trump Administration, US, USA

The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …

News
type_2_diabetes_28081593711_1

Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK

September 2, 2020
Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes

Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …

News
shutterstock_273326141

Nestlé to acquire remaining shares in Aimmune for $2.6 billion

September 2, 2020
Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma

Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026